Arenobufagin modulation of PCSK9-mediated cholesterol metabolism induces tumor-associated macrophages polarisation to inhibit hepatocellular carcinoma progression

Phytomedicine. 2024 Jun:128:155532. doi: 10.1016/j.phymed.2024.155532. Epub 2024 Mar 13.

Abstract

Background: The tumor microenvironment (TME) of hepatocellular carcinoma is heterogeneous enough to be prone to drug resistance and multidrug resistance during treatment, and reprogramming of cholesterol metabolism in TME mediates tumor-associated macrophages (TAMs) polarization, which has an impact on the regulation of malignant tumor progression. Arenobufagin (ARBU) was extracted and isolated from toad venom (purity ≥98 %), which is the main active ingredient of the traditional Chinese medicine Chan'su with good anti-tumor effects.

Purpose: To investigate the regulatory effect of ARBU on lipid metabolism in tumor microenvironment, interfere with macrophage polarization, and determine its mechanism of action on liver cancer progression.

Methods: In this study, the inhibitory effect of ARBU on the proliferation of Hepa1-6 in C57 mice and the safety of administration were evaluated by establishing a transplanted tumor model of Hepa1-6 hepatocellular carcinoma mice and using 5-FU as a positive control drug. In addition, we constructed a co-culture system of Hepa1-6 cells and primary mouse macrophages to study the effects of ARBU on the polarization phenotypic transformation of macrophages and the proliferation and migration of hepatoma cells. The influence of ARBU on the metabolism of lipids in the hepatocellular carcinoma mouse model was investigated by combining it with lipidomics technology. The influence of ARBU on the PCSK9/LDL-R signaling pathway and macrophage polarization, which regulate cholesterol metabolism, was tested by using qRT-PCR, gene editing, IF, and WB.

Conclusion: ARBU significantly inhibited the proliferation of Hepa1-6 in vivo and in vitro, regulated cholesterol metabolism, and promoted the M1-type polarization of macrophages in the tumor microenvironment. ARBU inhibits cholesterol synthesis in the TME through the PCSK9/LDL-R signaling pathway, thereby blocking macrophage M2 polarization, promoting apoptosis of the tumor cells, and inhibiting their proliferation and migration.

Keywords: Arenobufagin; Cholesterol metabolism; PCSK9 hepatocellular carcinoma; Tumor-associated macrophages.

MeSH terms

  • Amphibian Venoms / pharmacology
  • Animals
  • Bufanolides* / pharmacology
  • Carcinoma, Hepatocellular* / drug therapy
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Cell Proliferation* / drug effects
  • Cholesterol* / metabolism
  • Liver Neoplasms* / drug therapy
  • Male
  • Mice
  • Mice, Inbred C57BL*
  • Proprotein Convertase 9* / metabolism
  • Tumor Microenvironment* / drug effects
  • Tumor-Associated Macrophages* / drug effects

Substances

  • Bufanolides
  • Proprotein Convertase 9
  • Cholesterol
  • arenobufagin
  • Pcsk9 protein, mouse
  • Amphibian Venoms